| Cara Ann Dalbey, PSYD | |
|
923 Auburn Way N, Auburn, WA 98002-4117 | |
| (253) 352-3900 | |
| Not Available |
| Full Name | Cara Ann Dalbey |
|---|---|
| Gender | Female |
| Speciality | Clinical Psychologist |
| Experience | 16 Years |
| Location | 923 Auburn Way N, Auburn, Washington |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043442833 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 103T00000X | Psychologist | PY60048800 (Washington) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Healthpoint | 9335042886 | 142 |
News Archive
ShangPharma Corporation, a leading China-based pharmaceutical and biotechnology research and development outsourcing company, and Jiangsu Hengrui Medicine Co., Ltd., a leading Chinese pharmaceutical company, today announced that Shanghai ChemPartner, a wholly owned subsidiary of ShangPharma, and Hengrui have entered into a strategic partnership for the development of novel therapeutic monoclonal antibodies.
Tyrosinaemia type 1 is a rare, hereditary metabolic disease that, if left untreated, can already lead to serious liver and kidney damage in infancy.
Chestnut Global Partners (www.chestnutglobalpartners.org), a provider of culturally-aware employee assistance and wellness programs to companies worldwide, today announced that it has partnered with Leader Prospects, an HR and work/life consulting company based in India, to form CGP India (CGPI).
pSivida Corp., a leader in the development of sustained release drug delivery products for the treatment of back-of-the-eye disease including the product candidate Iluvien™ for the treatment of Diabetic Macular Edema, today announced that it has been awarded two grants totaling $489,000 under the IRS Qualifying Therapeutic Discovery Project (QTDP). The grants were awarded to pSivida to help fund further research on new generations of the company's drug delivery technologies targeting ophthalmic diseases.
Employers in Hawaii are required to pay 98.5 percent of the health insurance costs of full-time workers, an arrangement that has earned the state an exemption from the employer mandate in health reform bill being considered by the House of Representatives, the Associated Press reports.
› Verified 8 days ago
| Entity Name | Healthpoint |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1831199454 PECOS PAC ID: 9335042886 Enrollment ID: O20040206000245 |
News Archive
ShangPharma Corporation, a leading China-based pharmaceutical and biotechnology research and development outsourcing company, and Jiangsu Hengrui Medicine Co., Ltd., a leading Chinese pharmaceutical company, today announced that Shanghai ChemPartner, a wholly owned subsidiary of ShangPharma, and Hengrui have entered into a strategic partnership for the development of novel therapeutic monoclonal antibodies.
Tyrosinaemia type 1 is a rare, hereditary metabolic disease that, if left untreated, can already lead to serious liver and kidney damage in infancy.
Chestnut Global Partners (www.chestnutglobalpartners.org), a provider of culturally-aware employee assistance and wellness programs to companies worldwide, today announced that it has partnered with Leader Prospects, an HR and work/life consulting company based in India, to form CGP India (CGPI).
pSivida Corp., a leader in the development of sustained release drug delivery products for the treatment of back-of-the-eye disease including the product candidate Iluvien™ for the treatment of Diabetic Macular Edema, today announced that it has been awarded two grants totaling $489,000 under the IRS Qualifying Therapeutic Discovery Project (QTDP). The grants were awarded to pSivida to help fund further research on new generations of the company's drug delivery technologies targeting ophthalmic diseases.
Employers in Hawaii are required to pay 98.5 percent of the health insurance costs of full-time workers, an arrangement that has earned the state an exemption from the employer mandate in health reform bill being considered by the House of Representatives, the Associated Press reports.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Cara Ann Dalbey, PSYD 955 Powell Ave Sw, Health Point, Renton, WA 98057-0000 Ph: (425) 277-1311 | Cara Ann Dalbey, PSYD 923 Auburn Way N, Auburn, WA 98002-4117 Ph: (253) 352-3900 |
News Archive
ShangPharma Corporation, a leading China-based pharmaceutical and biotechnology research and development outsourcing company, and Jiangsu Hengrui Medicine Co., Ltd., a leading Chinese pharmaceutical company, today announced that Shanghai ChemPartner, a wholly owned subsidiary of ShangPharma, and Hengrui have entered into a strategic partnership for the development of novel therapeutic monoclonal antibodies.
Tyrosinaemia type 1 is a rare, hereditary metabolic disease that, if left untreated, can already lead to serious liver and kidney damage in infancy.
Chestnut Global Partners (www.chestnutglobalpartners.org), a provider of culturally-aware employee assistance and wellness programs to companies worldwide, today announced that it has partnered with Leader Prospects, an HR and work/life consulting company based in India, to form CGP India (CGPI).
pSivida Corp., a leader in the development of sustained release drug delivery products for the treatment of back-of-the-eye disease including the product candidate Iluvien™ for the treatment of Diabetic Macular Edema, today announced that it has been awarded two grants totaling $489,000 under the IRS Qualifying Therapeutic Discovery Project (QTDP). The grants were awarded to pSivida to help fund further research on new generations of the company's drug delivery technologies targeting ophthalmic diseases.
Employers in Hawaii are required to pay 98.5 percent of the health insurance costs of full-time workers, an arrangement that has earned the state an exemption from the employer mandate in health reform bill being considered by the House of Representatives, the Associated Press reports.
› Verified 8 days ago
Amanda Foster, Psychologist Medicare: Accepting Medicare Assignments Practice Location: 126 Auburn Ave, Suite 300, Auburn, WA 98002 Phone: 253-735-0166 | |
Nidhi Goel, Psychologist Medicare: Accepting Medicare Assignments Practice Location: 126 Auburn Ave Ste 300, Auburn, WA 98002 Phone: 253-833-1217 | |
Dr. Karen Hye, PSY.D. Psychologist Medicare: Accepting Medicare Assignments Practice Location: 205 10th St Ne, Suite 200, Auburn, WA 98002 Phone: 253-351-5320 |